CVR Medical Corp.

Equities

CVM.H

CA1266321084

Biotechnology & Medical Research

Delayed Toronto S.E. Other stock markets 20:12:33 05/05/2022 BST			5-day change	1st Jan Change
0.015 ^CAD	-25.00%		-.--%	-.--%

2022	CVR Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
2022	CVR Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI

CVR Medical Corp. Appoints James D'orta to Board of Directors

March 11, 2019 at 01:09 pm

CVR Medical Corp. announced that James D'Orta. has joined the Board of Directors. Dr. D'Orta joins CVR Medical's extensive leadership as the company moves toward market entry of its disruptive medical device, the Carotid Stenotic Scan (CSS). Dr. D'Orta currently services on the Board of Directors of Accuity Delivery Systems. Previously, he served as a Director of Cogentix Medical.

Latest news about CVR Medical Corp.

CVR Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	30/11/22	CI
CVR Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	07/09/22	CI
CVR Medical Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	20/07/22	CI
CVR Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	14/07/22	CI
CVR Medical Corp. Auditor Raises 'Going Concern' Doubt	13/07/22	CI
CVR Medical Corp. announced that it has received CAD 0.06016 million in funding	05/05/22	CI
CVR Medical Corp. announced that it expects to receive CAD 0.1 million in funding	11/04/22	CI
CVR Medical Corp. announced that it expects to receive CAD 0.1875 million in funding	17/01/22	CI
CVR Medical Corp. announced that it has received CAD 0.1155 million in funding	22/12/21	CI
CVR Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	28/11/21	CI
CVR Medical Corp. announced that it expects to receive CAD 0.15 million in funding	07/11/21	CI
CVR Medical Corp. Announces the Appointment of Darren Day as Chief Executive Officer	02/09/21	CI
Cvr Medical Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	31/08/21	CI
CVR Medical Corp. Announces Earnings Results for the First Quarter Ended March 31, 2021	01/06/21	CI
CVR Medical Corp. Announces Resignation of Harvey Mckenzie as Financial Advisor and Nominee to the Board of Directors	29/05/21	CI
CVR Medical Corp. Announces Resignation of Michael Rhodes as CEO	29/05/21	CI
Cvr Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	30/04/21	CI
CVR Medical Corp. Auditor Raises 'Going Concern' Doubt	29/04/21	CI
CVR Medical Corp. Appoints Michael Rhodes as Chief Executive Officer	19/01/21	CI
Cvr Medical Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020	30/11/20	CI
CVR Medical Corp. Announces Executive Changes	28/08/20	CI
CVR Medical Corp. Announces Executive Changes	28/08/20	CI
Cvr Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	11/08/20	CI
CVR Medical Corp. Auditor Raises 'Going Concern' Doubt	10/08/20	CI
CVR Medical Corp. Announces Resignation of Dallas Hack as Interim CEO, CFO and as Member of the Board of Directors	09/03/20	CI

Chart CVR Medical Corp.

Duration

Period

More charts

Company Profile

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Companyâs Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
CVR MEDICAL CORP.	-.--%	1.44M
EXACT SCIENCES CORPORATION	-44.11%	7.73B
GUARDANT HEALTH, INC.	+11.46%	3.7B
IOVANCE BIOTHERAPEUTICS, INC.	-1.11%	2.28B
BGI GENOMICS CO., LTD.	-21.56%	1.99B
VERACYTE, INC.	-23.81%	1.6B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+11.60%	999M
SEEGENE, INC.	-5.90%	687M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-37.55%	461M
CURIOX BIOSYSTEMS CO., LTD	-3.18%	279M

Bio Diagnostics & Testing